BIVIW
BioVie Inc. WarrantNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
—
Beta
0.57
52W High
$0.58
52W Low
$0.00
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About BioVie Inc. Warrant
BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease. The company is headquartered in Carson City, Nevada.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-20.37M |
| Operating Margin | 0.00% |
| Return on Equity | -106.40% |
| Return on Assets | -61.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $2.07 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $7.50M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
HV 10-Day
132.68%
HV 20-Day
147.59%
HV 30-Day
146.05%
HV 60-Day
139.88%
HV Rank
—
Volatility is currently contracting
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on BIVIW and any ticker you trade — then tracks every position and per-strategy win rate.
Data last updated: 7/29/2026